As Donald Trump is sworn into office today, we look at what the next 100 days and indeed the next four years could mean for the biopharma industry through his recent candidates for the top healthcare roles, his policies (which are still coming into focus), and the power that 140 characters can have.
{iframe}http://www.fiercebiotech.com/biotech/donald-trump-s-first-100-days-and-beyond-for-biopharma?utm_medium=nl&utm_source=internal&mrkid=920176&mkt_tok=eyJpIjoiWVRFeFl6WTNaR0kwTURNMCIsInQiOiJCdlh5eXVvQjlRQTI5WGM1b0ExcFREdFZ0R0dHbENqbmJOY0lSSTdmMmU5Z0pqZVArUkJIY3p1VlBOQStkZ0xjRHdmY1NKZ3VJWnQ3aTVuY2U4ZVhLblBcL2VibUlSTFh6ZUE0WUZhd0h6MVwvUnI2dHVRSTVKNlBNa0lJRkpCblpnIn0%3D{/iframe}